Human Wharton's Jelly-derived Mesenchymal Stem Cells Alleviate Concanavalin A-induced Fulminant Hepatitis by Repressing NF-κB Signaling and Glycolysis

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2021 Sep 10

PMID 34503553

Citations 12

Authors

Lijie Pan

Chang Liu

Qiuli Liu

Yanli Li

Cong Du

Xinmei Kang

Shuai Dong

Zhuowei Zhou

Huaxin Chen

Xiaoqi Liang

Jiajie Chu

Yan Xu

Qi Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Fulminant hepatitis is a severe life-threatening clinical condition with rapid progressive loss of liver function. It is characterized by massive activation and infiltration of immune cells into the liver and disturbance of inflammatory cytokine production. Mesenchymal stem cells (MSCs) showed potent immunomodulatory properties. Transplantation of MSCs is suggested as a promising therapeutic approach for a host of inflammatory conditions.

Methods: In the current study, a well-established concanavalin A (Con A)-induced fulminant hepatitis mouse model was used to investigate the effects of transplanting human umbilical cord Wharton's jelly-derived MSCs (hWJ-MSCs) on fulminant hepatitis.

Results: We showed that hWJ-MSCs effectively alleviate fulminant hepatitis in mouse models, primarily through inhibiting T cell immunity. RNA sequencing of liver tissues and human T cells co-cultured with hWJ-MSCs showed that NF-κB signaling and glycolysis are two main pathways mediating the protective role of hWJ-MSCs on both Con A-induced hepatitis in vivo and T cell activation in vitro.

Conclusion: In summary, our data confirmed the potent therapeutic role of MSCs-derived from Wharton's jelly of human umbilical cord on Con A-induced fulminant hepatitis, and uncovered new mechanisms that glycolysis metabolic shift mediates suppression of T cell immunity by hWJ-MSCs.

Citing Articles

Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis.

Yang F, Ni B, Liang X, He Y, Yuan C, Chu J Stem Cell Res Ther. 2025; 16(1):4.

PMID: 39773662 PMC: 11706160. DOI: 10.1186/s13287-024-04013-7.

Mesenchymal stromal cells alleviate APAP-induced liver injury via extracellular vesicle-mediated regulation of the miR-186-5p/CXCL1 axis.

Zhao E, Liang R, Li P, Lu D, Chen S, Tan W Stem Cell Res Ther. 2024; 15(1):392.

PMID: 39490995 PMC: 11533353. DOI: 10.1186/s13287-024-03995-8.

Evaluation of the impact of customized serum-free culture medium on the production of clinical-grade human umbilical cord mesenchymal stem cells: insights for future clinical applications.

Zhao L, Ni B, Li J, Liu R, Zhang Q, Zheng Z Stem Cell Res Ther. 2024; 15(1):327.

PMID: 39334391 PMC: 11438183. DOI: 10.1186/s13287-024-03949-0.

Research progress and prospects of benefit-risk assessment methods for umbilical cord mesenchymal stem cell transplantation in the clinical treatment of spinal cord injury.

Shen R, Lu Y, Cai C, Wang Z, Zhao J, Wu Y Stem Cell Res Ther. 2024; 15(1):196.

PMID: 38956734 PMC: 11218107. DOI: 10.1186/s13287-024-03797-y.

Mesenchymal stem/stromal cells armored by FGF21 ameliorate alcohol-induced liver injury through modulating polarization of macrophages.

Huai Q, Zhu C, Zhang X, Dai H, Li X, Wang H Hepatol Commun. 2024; 8(4).

PMID: 38551384 PMC: 10984668. DOI: 10.1097/HC9.0000000000000410.

References

Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z . Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012; 1(10):725-31. PMC: 3659658. DOI: 10.5966/sctm.2012-0034. View

Zhu X, He B, Zhou X, Ren J . Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis. Cell Tissue Res. 2012; 351(3):477-86. DOI: 10.1007/s00441-012-1524-3. View

Louis H, Le Moine O, Peny M, Quertinmont E, Fokan D, Goldman M . Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology. 1997; 25(6):1382-9. DOI: 10.1002/hep.510250614. View

Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y . Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther. 2010; 18(10):1857-64. PMC: 2951565. DOI: 10.1038/mt.2010.155. View

Ma E, Verway M, Johnson R, Roy D, Steadman M, Hayes S . Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8 T Cells. Immunity. 2019; 51(5):856-870.e5. DOI: 10.1016/j.immuni.2019.09.003. View

Kubo N, Narumi S, Kijima H, Mizukami H, Yagihashi S, Hakamada K . Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A. J Gastroenterol Hepatol. 2011; 27(1):165-72. DOI: 10.1111/j.1440-1746.2011.06798.x. View

Poggi A, Zocchi M . Immunomodulatory Properties of Mesenchymal Stromal Cells: Still Unresolved "Yin and Yang". Curr Stem Cell Res Ther. 2018; 14(4):344-350. DOI: 10.2174/1574888X14666181205115452. View

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

10.

Chen L, Qu J, Mei Q, Chen X, Fang Y, Chen L . Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine. Stem Cell Res Ther. 2021; 12(1):433. PMC: 8330084. DOI: 10.1186/s13287-021-02511-6. View

11.

Lightner A, Dozois E, Dietz A, Fletcher J, Friton J, Butler G . Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas. Inflamm Bowel Dis. 2019; 26(5):670-677. DOI: 10.1093/ibd/izz215. View

12.

Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F . Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med. 2000; 191(1):105-14. PMC: 2195789. DOI: 10.1084/jem.191.1.105. View

13.

Nasti A, Sakai Y, Seki A, Buffa G, Komura T, Mochida H . The CD45 fraction in murine adipose tissue derived stromal cells harbors immune-inhibitory inflammatory cells. Eur J Immunol. 2017; 47(12):2163-2174. DOI: 10.1002/eji.201646835. View

14.

Peng Y, Chen X, Zhang X, Huang K, Liu L, Li H . Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia. 2014; 29(3):636-46. DOI: 10.1038/leu.2014.225. View

15.

Antony A, Rodby K, Tobin M, OConnor M, Pearl R, DiPietro L . Composite tissue allotransplantation and dysregulation in tissue repair and regeneration: a role for mesenchymal stem cells. Front Immunol. 2013; 4:188. PMC: 3705198. DOI: 10.3389/fimmu.2013.00188. View

16.

Singer N, Caplan A . Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2010; 6:457-78. DOI: 10.1146/annurev-pathol-011110-130230. View

17.

Kusters S, Gantner F, Kunstle G, Tiegs G . Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 1996; 111(2):462-71. DOI: 10.1053/gast.1996.v111.pm8690213. View

18.

Campagnoli C, Roberts I, Kumar S, Bennett P, Bellantuono I, Fisk N . Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001; 98(8):2396-402. DOI: 10.1182/blood.v98.8.2396. View

19.

Lawless S, Kedia-Mehta N, Walls J, McGarrigle R, Convery O, Sinclair L . Glucose represses dendritic cell-induced T cell responses. Nat Commun. 2017; 8:15620. PMC: 5459989. DOI: 10.1038/ncomms15620. View

20.

Lin B, Chen J, Qiu W, Wang K, Xie D, Chen X . Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial. Hepatology. 2017; 66(1):209-219. DOI: 10.1002/hep.29189. View